Baillie Gifford & Co’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-181,626
| Closed | -$441K | – | 290 |
|
2023
Q2 | $441K | Hold |
181,626
| – | – | ﹤0.01% | 276 |
|
2023
Q1 | $1.05M | Hold |
181,626
| – | – | ﹤0.01% | 265 |
|
2022
Q4 | $1.62M | Hold |
181,626
| – | – | ﹤0.01% | 263 |
|
2022
Q3 | $2.58M | Hold |
181,626
| – | – | ﹤0.01% | 260 |
|
2022
Q2 | $2.65M | Hold |
181,626
| – | – | ﹤0.01% | 260 |
|
2022
Q1 | $3.63M | Hold |
181,626
| – | – | ﹤0.01% | 259 |
|
2021
Q4 | $3.18M | Hold |
181,626
| – | – | ﹤0.01% | 264 |
|
2021
Q3 | $1.42M | Hold |
181,626
| – | – | ﹤0.01% | 268 |
|
2021
Q2 | $1.87M | Hold |
181,626
| – | – | ﹤0.01% | 264 |
|
2021
Q1 | $2.38M | Hold |
181,626
| – | – | ﹤0.01% | 255 |
|
2020
Q4 | $2.55M | Hold |
181,626
| – | – | ﹤0.01% | 241 |
|
2020
Q3 | $2.16M | Sell |
181,626
-1
| -0% | -$12 | ﹤0.01% | 231 |
|
2020
Q2 | $2.73M | Hold |
181,627
| – | – | ﹤0.01% | 215 |
|
2020
Q1 | $1.31M | Hold |
181,627
| – | – | ﹤0.01% | 199 |
|
2019
Q4 | $1.9M | Hold |
181,627
| – | – | ﹤0.01% | 201 |
|
2019
Q3 | $11.2M | Hold |
181,627
| – | – | 0.01% | 175 |
|
2019
Q2 | $13M | Hold |
181,627
| – | – | 0.01% | 181 |
|
2019
Q1 | $8.67M | Buy |
181,627
+41,110
| +29% | +$1.96M | 0.01% | 189 |
|
2018
Q4 | $8.48M | Hold |
140,517
| – | – | 0.01% | 188 |
|
2018
Q3 | $14.9M | Buy |
140,517
+13,343
| +10% | +$1.41M | 0.02% | 169 |
|
2018
Q2 | $8.15M | Buy |
127,174
+48,603
| +62% | +$3.11M | 0.01% | 182 |
|
2018
Q1 | $5.27M | Buy |
+78,571
| New | +$5.27M | 0.01% | 190 |
|